GRITSTONE BIO, INC.

Analyst Reco. Gritstone bio, Inc.

Equities

GRTS

US39868T1051

Market Closed - Nasdaq Other stock markets 02:00:00 04/05/2024 am IST			5-day change	1st Jan Change
0.9627 ^USD	+10.66%		+18.36%	-52.81%

30/04	Gritstone Bio, Inc. Highlights the Durability and Potential Broad Utility of its Self-amplifying mRNA Vaccine at ESCMID Global 2024	CI
29/04	Gritstone Bio, Inc. Announces Board Changes	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

B. Riley Adjusts Gritstone bio's Price Target to $6 From $8, Keeps Buy Rating	07/12	MT
Piper Sandler Lifts Price Target on Gritstone bio to $7 From $6, Keeps Overweight Rating	28/23/28	MT
B. Riley Initiates Coverage of Gritstone bio With Buy Rating, Price Target of $8 Per Share	28/23/28	MT
HC Wainwright Adjusts Gritstone bio's Price Target to $7 From $12, Keeps Buy Rating	07/22/07	MT
Piper Sandler Starts Gritstone bio at Overweight With $6 Price Target	31/22/31	MT
Goldman Sachs Downgrades Gritstone bio to Sell From Neutral; Price Target is $2	22/22/22	MT
HC Wainwright Lowers Gritstone bio's Price Target to $12 From $15, Maintains Buy Rating	09/22/09	MT
HC Wainwright Adjusts Gritstone Bio's Price Target to $15 From $24, Maintains Buy Rating	14/22/14	MT
GRITSTONE ONCOLOGY : BTIG Research Adjusts Gritstone Oncology PT to $35 From $17, Maintains Buy Rating	21/21/21	MT
GRITSTONE ONCOLOGY : HC Wainwright Adjusts Gritstone Oncology's Price Target to $24 from $16, Keeps Buy Rating	20/21/20	MT
GRITSTONE ONCOLOGY : Baird Downgrades Gritstone Oncology to Underperform From Outperform; Price Target is $8	20/21/20	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

The best tools reserved for subscribers to boost the performance of your investments!

Optimize my profits

fermer